Nectero Medical

Nectero Therapeutics – Nectero Therapeutics is developing a novel treatment to stabilize growth and prevent rupture of mid-sized abdominal aortic aneurysms (AAA).

Tempe, United States · Founded 2017 · $115.5M raised

Headquarters
Tempe, Arizona
Employees
11–50
Founded
2017
Business Model
B2B
Total Funding
$115.5M
Last Round
$96.0M Series DApr 2024
Rounds
2

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

About

Nectero Medical (now Nectero Therapeutics) is a clinical-stage biotech company developing the Nectero EAST® System, a minimally invasive endovascular procedure that delivers a stabilizing agent to strengthen the aortic wall and slow growth of small to medium-sized abdominal aortic aneurysms. The company received FDA Fast Track and Breakthrough Therapy designations in 2023 and raised a $94M Series D to advance its Phase II/III trial.

Summary

Nectero Medical is a Biotech company based in Tempe, United States, founded in 2017. It has raised $115.5M in total across 2 rounds, most recently a $96.0M Series D round in Apr 2024. Investors include Boston Scientific Corporation, Norwest Venture Partners and BioStar Capital.

Tech & App Stack

2 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series DSeries DApr 2024
$96.0M

Sign up to see all 2 events

Funding: Series C through Series D. Amounts, valuations, and investors where available.

Investors

Similar Companies

Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020
BridgeBioIPO

BridgeBio develops treatments for genetic conditions through autonomous condition-focused teams s...

San Francisco Bay Area, United States201–500Biotech, Healthcare
Growth EquityTotal funding$2.7BJul 2026

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Nectero Medical on Indexed.vc
<a href="https://indexed.vc/companies/nectero-medical"><img src="https://indexed.vc/api/badge/company/nectero-medical" alt="Nectero Medical on Indexed.vc" width="260" height="76" /></a>